SCHEMBL1667494

SCHEMBL1667494

Cc1n[nH]c(C)c1C(=O)Nc1ccc(Nc2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 2/20 0.46
EGFR P00533 5/20 0.42
MAPT P10636 5/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
GAA P10253 2/20 0.42
HPGDS O60760 1/20 0.41
HTR1B P28222 1/20 0.41
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 2/20 0.41
USP2 O75604 1/20 0.40
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667497 0.96 MAPT (0.48) PDE7AMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL1664638 0.82 EGFR (0.44) PDE7AEGFRMAPTSMN1; SMN2NPC1
SCHEMBL1664639 0.79 RAB9A (0.50) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL1664249 0.78 NPC1 (0.46) PDE7AMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL6126340 0.77 PDE7A (0.44) PDE7AEGFRMAPTSMN1; SMN2NPC1
SCHEMBL6126341 0.77 PDE7A (0.44) PDE7AEGFRMAPTSMN1; SMN2NPC1
SCHEMBL8769706 0.77 RAB9A (0.58) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL1664033 0.77 MAPT (0.46) PDE7AMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL1664332 0.77 RAB9A (0.57) MAPTSMN1; SMN2NPC1RAB9ALMNA
SCHEMBL1664754 0.76 NPC1 (0.46) PDE7AMAPTSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed